The present study was designed to assess whether platelet 5-HT2A receptor and IRAS/nischarin (I1-IR) could serve as peripheral biomarkers for comorbid CUD/MDD with a potential to discriminate between cocaine-induced and primary MDD at basal level and after ATD. The gene discussed is NISCH; the disease is Jeune syndrome.